TAK-272 (imarikiren), a novel renin inhibitor, improves cardiac remodeling and mortality in a murine heart failure model

por Hara, Tomoya, Nishimura, Satoshi, Yamamoto, Toshihiro, Kajimoto, Yumiko, Kusumoto, Keiji, Kanagawa, Ray, Ikeda, Shota, Nishimoto, Tomoyuki
Publicado 2018

Discovery of TAK-272: A Novel, Potent, and Orally Active Renin Inhibitor

por Imaeda, Yasuhiro, Tokuhara, Hidekazu, Fukase, Yoshiyuki, Kanagawa, Ray, Kajimoto, Yumiko, Kusumoto, Keiji, Kondo, Mitsuyo, Snell, Gyorgy, Behnke, Craig A., Kuroita, Takanobu
Publicado 2016